RE: “Biggy Pharma”.. LOL19 Feb 2026 11:11
If it is as good as what it was pumped by leadership last year…..$100bn market to go after and $10bn diagnostic tests, then let’s discount that by 95%…we get a $5bn market cap.
If it truly is as good as discussed, then the company that we had lined up to do a deal with in September will have a few rivals eager to make a deal with us.
That’s why things are taking longer, the value is being bid up. The company that gets the deal gets the prize. Meanwhile the rivals, even if they can’t afford the deal will be increasing their offers to at least make the offer expensive.
We are sitting waiting here for the bidding process to play out, hence the wait for £3 a share offer or higher.
At least that’s what I’m hoping….